PATIENT Act of 2023
Latest action · Dec 17, 2024 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMay 22, 2023
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023
This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps.
Specifically, the bill provides statutory authority for the requirement that hospitals publish an annual list of shoppable services they provide, including specified pricing information. Beginning in 2025, a hospital may not use an internet-based price estimator tool to meet the publication requirement for shoppable services.
The bill also modifies the health insurance plan disclosure requirements to include the rates for certain in-network services and prescription drug payment information.
The bill further requires providers of diagnostic laboratory tests under Medicare to publish online certain price information. Medicare Advantage (MA) organizations must report information about payments made to providers in which the MA organization has an ownership interest. Medicare prescription drug plan sponsors must report certain price information for covered drugs.
Additionally, the bill requires health insurance plan issuers (or the PBM providing services on behalf of the plan) to report to the plan sponsor specified information about prescription drugs dispensed under the plan. This includes rebates, fees, alternative discounts, or other remuneration the plan receives from drug manufacturers.
Finally, the bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid.
Cosponsors 88
Members who signed on, in the order they did. Signatures ran from May 22, 2023 to Sep 29, 2023; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NJ | Frank Pallone, Jr. | Original | May 22, 2023 |
| R-GA | Earl L. "Buddy" Carter | Jun 7, 2023 | |
| D-MN | Angie Craig | Jun 21, 2023 | |
| D-NH | Ann M. Kuster | Jun 21, 2023 | |
| R-OH | Bill Johnson | Jun 21, 2023 | |
| R-KY | Brett Guthrie | Jun 21, 2023 | |
| R-TN | Diana Harshbarger | Jun 21, 2023 | |
| R-FL | Gus M. Bilirakis | Jun 21, 2023 | |
| R-CA | Jay Obernolte | Jun 21, 2023 | |
| R-PA | John Joyce | Jun 21, 2023 | |
| D-MD | John P. Sarbanes | Jun 21, 2023 | |
| R-FL | Kat Cammack | Jun 21, 2023 | |
| R-IN | Larry Bucshon | Jun 21, 2023 | |
| D-CA | Nanette Diaz Barragán | Jun 21, 2023 | |
| R-FL | Neal P. Dunn | Jun 21, 2023 |
Committees 3
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 22, 2023Markup May 24, 2023 |
| House | Ways and Means Committee | Referred May 22, 2023 |
| Health Subcommittee | Referred Dec 17, 2024 | |
| House | Education and Workforce Committee | Referred May 22, 2023 |
Actions 5
Everything that happened, newest first.
- Dec 17, 2024Referred to the Subcommittee on Health.
- May 24, 2023Committee Consideration and Mark-up Session Held.
- May 24, 2023Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
- May 22, 2023Introduced in House
- May 22, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Congressional Budget Office cost estimate
- Jul 11, 2023Estimated Direct Spending and Revenue Effects of H.R. 3561, the PATIENT Act of 2023As Ordered Reported by the House Committee on Energy and Commerce on May 24, 2023
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 86, May 22, 2023, page H2501.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| S. Hrg. 118-661 | CONSOLIDATION AND CORPORATE OWNERSHIP IN HEALTH CARE: TRENDS AND IMPACTS ON ACCESS, QUALITY, AND COSTS177 pages | Finance Committee | Jun 8, 2023 |
Related bills 12
Companion bills and other measures the record links to this one.
Titles 3
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To promote hospital and insurer price transparency, and for other purposes.
- Short Title(s) as Introduced
- PATIENT Act of 2023
- Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Accounting and auditing
- Appropriations
- Business records
- Civil actions and liability
- Community life and organization
- Computers and information technology
- Congressional oversight
- Digestive and metabolic diseases
- Freedom of information
- Government information and archives
- Government studies and investigations
- Health
- Health care costs and insurance
- Health facilities and institutions
- Health information and medical records
- Health programs administration and funding
- Home and outpatient care
- Hospital care
- Indian social and development programs
- Internet, web applications, social media
- Medicaid
- Medical education
- Medical tests and diagnostic methods
- Medicare
- National and community service
- Prescription drugs
- State and local finance
- State and local government operations
Text 1
Each version as it was printed, newest first.
- May 22, 2023Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
